Emergent Biosolutions is a global specialty biopharmaceutical company offering specialized products that address medical needs and emerging health threats. The Company focuses on protecting and enhancing life by providing specialty products for civilian and military populations that address accidental, intentional and naturally emerging public health threats. Emergent Biosolutions focuses on developing, manufacturing and commercializing medical countermeasures that address public health threats. 

Type
Public
HQ
Gaithersburg, US
Founded
1998
Size (employees)
1,098 (est)
Emergent Biosolutions was founded in 1998 and is headquartered in Gaithersburg, US
Report incorrect company information

Emergent Biosolutions Office Locations

Emergent Biosolutions has offices in Bruchsal, Washington, Lansing, Winnipeg and in 6 other locations
Gaithersburg, US (HQ)
400 400 Professional Dr
Baltimore, US
5901 E Lombard St
Baltimore, US
1111 S Paca St
Hattiesburg, US
46 Shelby Thames Dr
Lansing, US
3500 N Martin Luther King Jr Blvd
Seattle, US
1050 2401 4th Ave
Show all (11)
Report incorrect company information

Emergent Biosolutions Financials and Metrics

Emergent Biosolutions Financials

Emergent Biosolutions's revenue was reported to be $488.78 m in FY, 2016 which is a 0.1% decrease from the previous period.
USD

Revenue (Q3, 2017)

149.4 m

Net income (Q3, 2017)

33.6 m

EBIT (Q3, 2017)

47.8 m

Market capitalization (23-Apr-2018)

2.7 b

Cash (30-Sep-2017)

341 m
Emergent Biosolutions's current market capitalization is $2.7 b.
Annual
USDFY, 2014FY, 2015FY, 2016

Revenue

404.5 m489.3 m488.8 m

Revenue growth, %

21%0%

General and administrative expense

143.7 m

R&D expense

108.3 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

89.1 m53.9 m110.3 m138 m63.6 m126.1 m164.9 m111 m101.5 m142.9 m116.9 m100.8 m149.4 m

Cost of goods sold

20.1 m

Gross profit

69 m

Gross profit Margin, %

77%
Annual
USDFY, 2014FY, 2015FY, 2016

Cash

280.5 m312.8 m271.5 m

Accounts Receivable

58.8 m120.8 m138.5 m

Inventories

65.7 m76.9 m74 m

Current Assets

432.2 m538.6 m510.2 m
Quarterly
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

214.8 m308.7 m341 m333.4 m298.9 m270.2 m315.6 m341 m

Accounts Receivable

99.7 m57 m69.6 m66.7 m69.6 m128.1 m102.5 m129.4 m

Inventories

84.7 m80.1 m88.2 m96.7 m81.2 m70.7 m70.5 m68.9 m

Current Assets

435.5 m473.5 m528.2 m528 m480 m489.2 m509.7 m556 m
Annual
USDFY, 2014FY, 2015FY, 2016

Net Income

36.7 m62.9 m51.8 m

Inventories

4.2 m(11.3 m)(9 m)

Accounts Payable

(9.3 m)4.7 m(14.8 m)

Cash From Operating Activities

112.3 m44.5 m53.5 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

15 m(20.2 m)(15.2 m)6.6 m(21.5 m)(7.4 m)29.5 m4 m(7 m)14.4 m10.5 m15.1 m48.7 m

Depreciation and Amortization

13.5 m6.8 m15.3 m24.3 m8.5 m17.3 m25.9 m8.8 m17.8 m28.2 m10.2 m20.1 m29.9 m

Inventories

(1.2 m)(4 m)1.2 m4.7 m(16.5 m)(19 m)(14.4 m)(11.3 m)(19.7 m)(16.2 m)3.3 m3.5 m5.1 m

Accounts Payable

(1.6 m)(10.7 m)(10.4 m)(11.2 m)1.1 m2.1 m1.9 m385 k11.3 m(1.3 m)81 k4.2 m3 m
USDY, 2017

Revenue/Employee

136.1 k

Financial Leverage

1.5 x
Show all financial metrics
Report incorrect company information